Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major
NCT ID: NCT04367701
Last Updated: 2020-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2012-01-15
2019-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complications in Children With B- Thalassemia Major
NCT03462784
Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia
NCT05469230
Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
NCT00971880
Thrombophilia In Beta Thalassemia
NCT04219449
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
NCT05370677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thalassemia group
16 pediatric patients with thalassemia major undergoing surgery for repair of congenital heart disease.
Authors measure hemolysis by free plasma hemoglobin concentration.
Hemolysis
Authors measured free plasma hemoglobin concentration in gram
Control group
25 pediatric patients with demographic data related to those in thalassemia group, undergoing surgery for repair of congenital heart disease.
Authors measure hemolysis by free plasma hemoglobin concentration
Hemolysis
Authors measured free plasma hemoglobin concentration in gram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemolysis
Authors measured free plasma hemoglobin concentration in gram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pediatric Patients with congenital heart disease undergoing surgical repair.
Exclusion Criteria
* uncontrolled active hemolytic reaction
* emergency surgery
* redo surgery
6 Months
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
simon Halim Armanious
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galal Mo El kadi, Doctor
Role: STUDY_CHAIR
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Thalassemia CHD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.